As of the latest Form 4 filed Jun 30, 2026.
What The Hanover Insurance Group Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 58 most recent filings for THG.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-06-26 | LANE KATHY S Director | AAward | +3.77 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Egan Cynthia Director | AAward | +3.77 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Carlin Jane D Director | AAward | +3.77 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Bunting Theodore H JR Director | AAward | +3.77 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Donnell William E. Director | AAward | +3.77 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Bradicich Kevin Director | AAward | +3.77 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Aristeguieta Francisco Director | AAward | +3.77 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Condrin J Paul Director | AAward | +3.77 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | RAMRATH JOSEPH R Director | AAward | +3.77 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Ward Elizabeth A Director | AAward | +3.77 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Salvatore Bryan J Executive Vice President | AAward | +24.58 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Roche John C President and CEO | AAward | +122.23 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Norton-Gatto Patricia A. SVP & Princpl. Accntg. Officer | AAward | +5.76 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | LOVELY DAVID JOHN Executive Vice President | AAward | +10.61 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Lee Willard T Executive Vice President | AAward | +10.83 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | LAVEY RICHARD W Executive Vice President | AAward | +28.41 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Kerrigan Dennis Francis Executive Vice President | AAward | +15.22 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | FARBER JEFFREY M Executive Vice President | AAward | +42.66 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-03 | Salvatore Bryan J Executive Vice President | SSale | −16.4K | $185.76 | $3.05M | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-03 | Salvatore Bryan J, Executive Vice President | MExercise | +16.4K | $104.11 | $1.71M | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Aristeguieta Francisco Director | SSale | −1.00K | $195.37 | $195K | No | Form 4 ↗ |
| 2026-05-21 | 2026-05-20 | Kerrigan Dennis Francis Executive Vice President | SSale | −6.26K | $192.99 | $1.21M | No | Form 4 ↗ |
| 2026-05-21 | 2026-05-20 | Kerrigan Dennis Francis, Executive Vice President | MExercise | +6.26K | $115.35 | $722K | No | Form 4 ↗ |
| 2026-05-21 | 2026-05-20 | Roche John C President and CEO | SSale | −61.00 | $194.77 | $11.9K | Yes (planned) | Form 4 ↗ |
| 2026-05-21 | 2026-05-20 | Roche John C, President and CEO | SSale | −5.14K | $194.05 | $998K | Yes (planned) | Form 4 ↗ |
| 2026-05-21 | 2026-05-20 | Roche John C, President and CEO | SSale | −3.15K | $193.21 | $609K | Yes (planned) | Form 4 ↗ |
| 2026-05-21 | 2026-05-19 | Roche John C, President and CEO | FTax | −24.8K | $193.79 | $4.80M | Yes (planned) | Form 4 ↗ |
| 2026-05-21 | 2026-05-19 | Roche John C, President and CEO | MExercise | +24.0K | $104.11 | $2.50M | Yes (planned) | Form 4 ↗ |
| 2026-05-21 | 2026-05-19 | Roche John C, President and CEO | MExercise | +9.10K | $85.87 | $781K | Yes (planned) | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Roche John C President and CEO | SSale | −100.00 | $199.23 | $19.9K | Yes (planned) | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Roche John C, President and CEO | SSale | −2.52K | $198.65 | $500K | Yes (planned) | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Roche John C, President and CEO | SSale | −2.26K | $197.61 | $447K | Yes (planned) | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Roche John C, President and CEO | SSale | −375.00 | $196.55 | $73.7K | Yes (planned) | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | Roche John C, President and CEO | FTax | −12.9K | $194.64 | $2.52M | Yes (planned) | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | Roche John C, President and CEO | MExercise | +18.2K | $85.87 | $1.56M | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-14 | Lowsley Denise Executive Vice President | SSale | −4.17K | $191.73 | $800K | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-14 | Lowsley Denise, Executive Vice President | MExercise | +4.17K | $115.35 | $482K | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | Donnell William E. Director | AAward | +843.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | Ward Elizabeth A Director | AAward | +843.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | Condrin J Paul Director | AAward | +843.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | Bradicich Kevin Director | AAward | +843.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | Egan Cynthia Director | AAward | +843.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | Aristeguieta Francisco Director | AAward | +843.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | Carlin Jane D Director | AAward | +843.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | Bunting Theodore H JR Director | AAward | +843.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | LANE KATHY S Director | AAward | +843.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | RAMRATH JOSEPH R Director | AAward | +843.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-11 | 2026-05-08 | Lowsley Denise Executive Vice President | SSale | −1.06K | $188.43 | $200K | No | Form 4 ↗ |
| 2026-05-05 | 2026-05-04 | Lee Willard T Executive Vice President | SSale | −1.00K | $183.93 | $184K | No | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | Egan Cynthia Director | SSale | −3.40K | $188.50 | $641K | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-27 | Lee Willard T Executive Vice President | AAward | +13.52 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-27 | LOVELY DAVID JOHN Executive Vice President | AAward | +13.25 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-27 | Lowsley Denise Executive Vice President | AAward | +12.27 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-27 | FARBER JEFFREY M Executive Vice President | AAward | +53.25 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-27 | Kerrigan Dennis Francis Executive Vice President | AAward | +19.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-27 | LAVEY RICHARD W Executive Vice President | AAward | +35.47 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-27 | Roche John C President and CEO | AAward | +152.57 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-27 | Salvatore Bryan J Executive Vice President | AAward | +30.68 | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also THG’s full analysis or the market-wide insider trading feed. The tabs above jump to THG’s other SEC data.
Source: SEC Form 4 filings for THG, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.